Review of Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma

Pre-publication Review of

Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma

Reviewed On May 10, 2024

Verified

Submitted to

Reviewed by

Actions

Reviewed on May 10, 2024

Source

References

Maen, A., Abdullah, E., K., D. M., Jiaqiong, X., Sudha, K., W., V. D., Elizabeth, B., A., C. A., Ashish, S., Ahmed, E., O., K. A., Mark, G. R. 2024. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. Journal of Clinical Medicine.